{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:24:35Z","timestamp":1787653475248,"version":"build-2736575974"},"reference-count":110,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) remains a major global health challenge and one of the leading causes of cancer-related mortality, with advanced disease continuing to be associated with limited therapeutic options and substantial heterogeneity in response to systemic treatment. Recent evidence has established the gut microbiota, through the gut\u2013liver axis, as a critical determinant of immunotherapy efficacy, while also influencing antitumor immunity and liver carcinogenesis. Microbial dysbiosis may promote chronic inflammation, intestinal barrier disruption, bacterial translocation, and immune dysfunction, thereby contributing to hepatocarcinogenesis. Moreover, gut microbial composition and microbial-derived metabolites, including bile acids, short-chain fatty acids (SCFAs), and inosine, have been associated with modulation of antitumor immune responses and differential outcomes to immune checkpoint inhibitors (ICIs). Emerging clinical evidence in HCC has identified distinct gut microbial signatures associated with response to nivolumab, pembrolizumab, and atezolizumab-based regimens, including enrichment of Akkermansia muciniphila and SCFA-producing taxa such as Ruminococcaceae, Roseburia, and Prevotella in responders. However, these findings remain inconsistent across studies, with no reproducible microbial signature identified because of small cohort sizes, heterogeneous patient populations, geographic variation, cirrhosis-related confounding factors, and methodological differences in microbiome analysis. This review summarizes the current understanding of microbiome\u2013immune interactions in HCC, examines mechanistic pathways linking the microbiota to immunotherapy response, critically evaluates available clinical evidence, and discusses current limitations and future therapeutic strategies, including fecal microbiota transplantation, probiotics, dietary modulation, and engineered bacterial platforms. Collectively, microbiome-based approaches may contribute to the development of personalized immunotherapeutic strategies in HCC, although larger standardized prospective studies are required before microbiome-derived biomarkers can be implemented in routine clinical practice.<\/jats:p>","DOI":"10.3390\/ijms27177543","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:47:19Z","timestamp":1787572039000},"page":"7543","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbiome\u2013Immune Interactions as Determinants of Checkpoint Inhibitor Efficacy in Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"27","author":[{"given":"Madalina Raluca","family":"Ostafe","sequence":"first","affiliation":[{"name":"Department of Medical Oncology-Radiotherapy, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Ruxandra","family":"Volovat","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology-Radiotherapy, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Clement","sequence":"additional","affiliation":[{"name":"Regional Institute of Oncology, 700483 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezara Ioana","family":"Litcanu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology-Radiotherapy, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaranda Iuliana","family":"Tabarcea","sequence":"additional","affiliation":[{"name":"Regional Institute of Oncology, 700483 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian Constantin","family":"Volovat","sequence":"additional","affiliation":[{"name":"Department of Radiology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7650-7798","authenticated-orcid":false,"given":"Diana-Ioana","family":"Panaite","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology-Radiotherapy, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda Georgiana","family":"Augustin","sequence":"additional","affiliation":[{"name":"Department of Oncology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Volovat","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology-Radiotherapy, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e0932","DOI":"10.1097\/HC9.0000000000000932","article-title":"The Global Epidemiology of Hepatocellular Carcinoma","volume":"10","author":"Butt","year":"2026","journal-title":"Hepatol. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101571","DOI":"10.1016\/j.jhepr.2025.101571","article-title":"Hepatocellular Carcinoma: Epidemiology, Diagnosis and Treatment","volume":"7","author":"Mauro","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The Immunology of Hepatocellular Carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/cmi.2015.109","article-title":"Presentation of Hepatocellular Antigens","volume":"13","author":"Grakoui","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The Gut-Liver Axis in Liver Disease: Pathophysiological Basis for Therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the Liver\u2014From Homeostasis to Disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut Microbiome in HCC\u2014Mechanisms, Diagnosis and Therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut Microbiome Influences Efficacy of PD-1\u2013Based Immunotherapy against Epithelial Tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000024347","article-title":"IgG Immune Complex Binding to and Activation of Liver Cells","volume":"121","author":"Johansson","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The Gut\u2013Liver Axis and the Intersection with the Microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-0528.2002.017416.x","article-title":"Innate and Adaptive Lymphoid Cells in the Human Liver","volume":"174","author":"Doherty","year":"2000","journal-title":"Immunol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver Macrophages in Tissue Homeostasis and Disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"w13197","DOI":"10.4414\/smw.2011.13197","article-title":"Chronic Liver Inflammation and Hepatocellular Carcinoma: Persistence Matters","volume":"141","author":"Boege","year":"2011","journal-title":"Swiss Med. Wkly."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like Receptors and Adaptor Molecules in Liver Disease: Update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.02.005","article-title":"Tumor Regulation of the Tissue Environment in the Liver","volume":"173","author":"Eggert","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-022-01273-9","article-title":"Gut Microbiota Influence Immunotherapy Responses: Mechanisms and Therapeutic Strategies","volume":"15","author":"Lu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40425-019-0650-9","article-title":"Gut Microbiome Affects the Response to Anti-PD-1 Immunotherapy in Patients with Hepatocellular Carcinoma","volume":"7","author":"Zheng","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal Mucosal Barrier Function in Health and Disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc3610","article-title":"The Microbiome and Cancer","volume":"13","author":"Schwabe","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrmicro2977","article-title":"Competition Sensing: The Social Side of Bacterial Stress Responses","volume":"11","author":"Cornforth","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic Endotoxemia Initiates Obesity and Insulin Resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal Infusion of Donor Feces for Recurrent Clostridium Difficile","volume":"368","author":"Vrieze","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41423-025-01326-2","article-title":"The Gut Microbiota in Cancer Immunity and Immunotherapy","volume":"22","author":"Xie","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41564-024-01890-9","article-title":"Gut\u2013Liver Translocation of Pathogen Klebsiella Pneumoniae Promotes Hepatocellular Carcinoma in Mice","volume":"10","author":"Wang","year":"2025","journal-title":"Nat. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","article-title":"Imbalanced Gut Microbiota Fuels Hepatocellular Carcinoma Development by Shaping the Hepatic Inflammatory Microenvironment","volume":"13","author":"Schneider","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The Liver as a Lymphoid Organ","volume":"27","author":"Crispe","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like Receptor Signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: Mechanism of Action, Role in Disease, and Therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut Microbiota Impact on the Peripheral Immune Response in Non-Alcoholic Fatty Liver Disease Related Hepatocellular Carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.26694","article-title":"Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular Carcinoma","volume":"59","author":"Han","year":"2014","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e70262","DOI":"10.1002\/jev2.70262","article-title":"Gut Commensal Klebsiella Pneumoniae Extracellular Vesicles Shape a Liver Microenvironment Conducive to Gut-Liver Bacterial Translocation and Pro-Tumorigenic Processes","volume":"15","author":"Tsubaki","year":"2026","journal-title":"J. Extracell. Vesicles"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2112881","DOI":"10.1080\/19490976.2022.2112881","article-title":"Intestinal Microbiota Modulates Pancreatic Carcinogenesis through Intratumoral Natural Killer Cells","volume":"14","author":"Yu","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1016\/j.cell.2021.07.029","article-title":"Dysregulation of ILC3s Unleashes Progression and Immunotherapy Resistance in Colon Cancer","volume":"184","author":"Goc","year":"2021","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal Microbe-Derived Butyrate Induces the Differentiation of Colonic Regulatory T Cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut Microbiome and Liver Diseases","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zelante, T., Iannitti, R.G., Fallarino, F., Gargaro, M., De Luca, A., Moretti, S., Bartoli, A., and Romani, L. (2014). Tryptophan Feeding of the IDO1-AhR Axis in Host\u2013Microbial Symbiosis. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00640"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-020-00465-z","article-title":"Microbial Metabolite Boosts Immunotherapy","volume":"20","author":"Bird","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-Derived Inosine Modulates Response to Checkpoint Inhibitor Immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile Acid Metabolism and Signaling in Liver Disease and Therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","article-title":"Human Gut Bacteria Produce \u03a4H17-Modulating Bile Acid Metabolites","volume":"603","author":"Paik","year":"2022","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial Metabolism of Bile Acids Promotes Generation of Peripheral Regulatory T Cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-Induced Gut Microbial Metabolite Promotes Liver Cancer through Senescence Secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","article-title":"Gut Microbiome\u2013Mediated Bile Acid Metabolism Regulates Liver Cancer via NKT Cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e004779","DOI":"10.1136\/jitc-2022-004779","article-title":"Gut Microbiota and Metabolites Associate with Outcomes of Immune Checkpoint Inhibitor\u2013Treated Unresectable Hepatocellular Carcinoma","volume":"10","author":"Lee","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2022.03.039","article-title":"Uncoupling Immune Trajectories of Response and Adverse Events from Anti-PD-1 Immunotherapy in Hepatocellular Carcinoma","volume":"77","author":"Chuah","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral Dendritic Cell\u2013CD4+ T Helper Cell Niches Enable CD8+ T Cell Differentiation Following PD-1 Blockade in Hepatocellular Carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.32449","article-title":"Gut Microbiota\u2013Derived Short-chain Fatty Acids Regulate Group 3 Innate Lymphoid Cells in HCC","volume":"77","author":"Hu","year":"2023","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2519706","DOI":"10.1080\/19490976.2025.2519706","article-title":"Gut Microbial Metabolite Butyrate Suppresses Hepatocellular Carcinoma Growth via CXCL11-Dependent Enhancement of Natural Killer Cell Infiltration","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/gutjnl-2021-325288","article-title":"The Tumour Microenvironment Shapes Innate Lymphoid Cells in Patients with Hepatocellular Carcinoma","volume":"71","author":"Heinrich","year":"2022","journal-title":"Gut"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut Microbiome Modulates Response to Anti\u2013PD-1 Immunotherapy in Melanoma Patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/annonc\/mdx108","article-title":"Baseline Gut Microbiota Predicts Clinical Response and Colitis in Metastatic Melanoma Patients Treated with Ipilimumab","volume":"28","author":"Chaput","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neo.2017.08.004","article-title":"Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41591-022-01695-5","article-title":"Cross-Cohort Gut Microbiome Associations with Immune Checkpoint Inhibitor Response in Advanced Melanoma","volume":"28","author":"Lee","year":"2022","journal-title":"Nat. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal Microbiota Transplant Overcomes Resistance to Anti\u2013PD-1 Therapy in Melanoma Patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jtho.2019.04.007","article-title":"The Diversity of Gut Microbiome Is Associated with Favorable Responses to Anti\u2013Programmed Death 1 Immunotherapy in Chinese Patients with NSCLC","volume":"14","author":"Jin","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia Muciniphila Predicts Clinical Response to PD-1 Blockade in Patients with Advanced Non-Small-Cell Lung Cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.21037\/jtd-24-1201","article-title":"Gut Microbiota and Metabolites Associated with Immunotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Pilot Study","volume":"16","author":"Sun","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/2326-6066.CIR-20-0196","article-title":"The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non\u2013Small Cell Lung Cancer","volume":"8","author":"Hakozaki","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Matsumoto, Y., Hitaka, Y., Hirata, H., Yamamoto, Y., Kobayashi, K., Isoyama, N., Matsubara, T., Watanabe, K., Mizukami, Y., and Nakagawa, S. (2025). Exploration of Predictive Factors Based on Oral and Intestinal Bacterial Flora for Treating Patients with Urothelial Carcinoma. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0324814"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40364-024-00607-8","article-title":"Gut Microbiota and Metabolites Signatures of Clinical Response in Anti-PD-1\/PD-L1 Based Immunotherapy of Biliary Tract Cancer","volume":"12","author":"Zhu","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Shaikh, F.Y., Lee, S., White, J.R., Zhao, Y., Ferri, J.T., Pereira, G., Landon, B.V., Ke, S., Hu, C., and Feliciano, J.L. (2024). Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy. Cancers, 16.","DOI":"10.3390\/cancers16213644"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1002\/ctm2.1312","article-title":"The Gut Microbiome Affects Response of Treatments in HER2-negative Advanced Gastric Cancer","volume":"13","author":"Han","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep4.1905","article-title":"Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma","volume":"6","author":"Ponziani","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e008686","DOI":"10.1136\/jitc-2023-008686","article-title":"Characterizations of Multi-Kingdom Gut Microbiota in Immune Checkpoint Inhibitor-Treated Hepatocellular Carcinoma","volume":"12","author":"Zhu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Xin, Y., Peng, G., Song, W., Zhou, X., Huang, X., and Cao, X. (2024). Gut Microbiota as a Prognostic Biomarker for Unresectable Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy. Front. Genet., 15.","DOI":"10.3389\/fgene.2024.1366131"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Inukai, Y., Yamamoto, K., Honda, T., Yokoyama, S., Ito, T., Imai, N., Ishizu, Y., Nakamura, M., Ishigami, M., and Kawashima, H. (2024). Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers, 16.","DOI":"10.21203\/rs.3.rs-3996460\/v1"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.3748\/wjg.v27.i42.7340","article-title":"Gut Microbiome Composition Can Predict the Response to Nivolumab in Advanced Hepatocellular Carcinoma Patients","volume":"27","author":"Chung","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2147\/JHC.S315696","article-title":"An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma","volume":"8","author":"Shen","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41416-019-0466-x","article-title":"Clinical Implications of Heterogeneity in PD-L1 Immunohistochemical Detection in Hepatocellular Carcinoma: The Blueprint-HCC Study","volume":"120","author":"Pinato","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/liv.14706","article-title":"Qualification of Tumour Mutational Burden by Targeted Next-generation Sequencing as a Biomarker in Hepatocellular Carcinoma","volume":"41","author":"Wong","year":"2021","journal-title":"Liver Int."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Matsumae, T., Kodama, T., Myojin, Y., Maesaka, K., Sakamori, R., Takuwa, A., Oku, K., Motooka, D., Sawai, Y., and Oshita, M. (2022). Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy. Cancers, 14.","DOI":"10.3390\/cancers14143367"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"100672","DOI":"10.1016\/j.jhepr.2023.100672","article-title":"High Serum IL-6 Correlates with Reduced Clinical Benefit of Atezolizumab and Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"5","author":"Yang","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1002\/cam4.3135","article-title":"Predictive Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Advanced Hepatocellular Carcinoma Patients Treated with Anti\u2013PD-1 Therapy","volume":"9","author":"Dharmapuri","year":"2020","journal-title":"Cancer Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Xie, Y., and Liu, F. (2024). The Role of the Gut Microbiota in Tumor, Immunity, and Immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1410928"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","article-title":"Best Practices for Analysing Microbiomes","volume":"16","author":"Knight","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41420-025-02413-z","article-title":"Roles of the Gut Microbiota in Hepatocellular Carcinoma: From the Gut Dysbiosis to the Intratumoral Microbiota","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2012.11.023","article-title":"The Gut Microbiota and the Liver. Pathophysiological and Clinical Implications","volume":"58","author":"Quigley","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e00153\u201320","DOI":"10.1128\/msystems.00153-20","article-title":"Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma","volume":"5","author":"Lapidot","year":"2020","journal-title":"mSystems"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41591-018-0210-8","article-title":"The Influence of Ethnicity and Geography on Human Gut Microbiome Composition","volume":"24","author":"Gaulke","year":"2018","journal-title":"Nat. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s40168-018-0603-4","article-title":"A Comparative Study of the Gut Microbiota in Immune-Mediated Inflammatory Diseases\u2014Does a Common Dysbiosis Exist?","volume":"6","author":"Forbes","year":"2018","journal-title":"Microbiome"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1002\/cam4.3045","article-title":"Liver Cirrhosis Contributes to the Disorder of Gut Microbiota in Patients with Hepatocellular Carcinoma","volume":"9","author":"Zheng","year":"2020","journal-title":"Cancer Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/19490976.2020.1743492","article-title":"Vancomycin Prevents Fermentable Fiber-Induced Liver Cancer in Mice with Dysbiotic Gut Microbiota","volume":"11","author":"Singh","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2147\/JHC.S317957","article-title":"Antibiotic Therapy Is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib","volume":"8","author":"Pomej","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"100747","DOI":"10.1016\/j.jhepr.2023.100747","article-title":"Association between Antibiotics and Adverse Oncological Outcomes in Patients Receiving Targeted or Immune-Based Therapy for Hepatocellular Carcinoma","volume":"5","author":"Pinato","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_90","first-page":"E1306","article-title":"Probiotics Modulated Gut Microbiota Suppresses Hepatocellular Carcinoma Growth in Mice","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/19490976.2018.1527167","article-title":"The Intimate Relationship between Gut Microbiota and Cancer Immunotherapy","volume":"10","author":"Elkrief","year":"2019","journal-title":"Gut Microbes"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals with Steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Pomej, K., Frick, A., Scheiner, B., Balcar, L., Pajancic, L., Klotz, A., Kreuter, A., Lampichler, K., Regnat, K., and Zinober, K. (2025). Study Protocol: Fecal Microbiota Transplant Combined with Atezolizumab\/Bevacizumab in Patients with Hepatocellular Carcinoma Who Failed to Achieve or Maintain Objective Response to Atezolizumab\/Bevacizumab\u2014The FAB-HCC Pilot Study. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0321189"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e097802","DOI":"10.1136\/bmjopen-2024-097802","article-title":"Protocol: Faecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab\/Bevacizumab\u2014A Multicentre, Randomised, Placebo-Controlled, Double-Blind Phase II Trial (the FLORA Trial)","volume":"15","author":"Rauber","year":"2025","journal-title":"BMJ Open"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The Human Intestinal Microbiome in Health and Disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary Cholesterol Drives Fatty Liver-Associated Liver Cancer by Modulating Gut Microbiota and Metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cmet.2024.04.015","article-title":"A 5:2 Intermittent Fasting Regimen Ameliorates NASH and Fibrosis and Blunts HCC Development via Hepatic PPAR\u03b1 and PCK1","volume":"36","author":"Gallage","year":"2024","journal-title":"Cell Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"101056","DOI":"10.1016\/j.jhepr.2024.101056","article-title":"Maternal Obesity Increases the Risk of Hepatocellular Carcinoma through the Transmission of an Altered Gut Microbiome","volume":"6","author":"Moeckli","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2599729","DOI":"10.1080\/20565623.2025.2599729","article-title":"Obesity-Induced Gut Microbiota Transplantation Promotes the Occurrence and Development of Hepatocellular Carcinoma","volume":"11","author":"Wu","year":"2025","journal-title":"Future Sci. OA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"117338","DOI":"10.1016\/j.bcp.2025.117338","article-title":"Coffee for the Liver: A Mechanistic Approach","volume":"242","author":"Muriel","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","article-title":"Microbiome and Anticancer Immunosurveillance","volume":"165","author":"Zitvogel","year":"2016","journal-title":"Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","article-title":"Bioengineering of Bacteria for Cancer Immunotherapy","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41698-025-00960-3","article-title":"Bifidobacterium Boosts Anti-PD-1 Effectiveness through JAK Pathway in Hepatocellular Carcinoma","volume":"9","author":"Huo","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/s41388-026-03701-3","article-title":"Modulating Gut Microbiota to Enhance Anti-PD-1\/PD-L1 Immunotherapy in Hepatocellular Carcinoma: The Role of Lactobacillus Kefiranofaciens and SOCS3 Regulation","volume":"45","author":"Lv","year":"2026","journal-title":"Oncogene"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1038\/s41591-024-03086-4","article-title":"Cabozantinib and Nivolumab with or without Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma: A Randomized Phase 1 Trial","volume":"30","author":"Ebrahimi","year":"2024","journal-title":"Nat. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-Gut Microbiota Metabolic Interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1158\/1055-9965.EPI-15-0951","article-title":"Collecting Fecal Samples for Microbiome Analyses in Epidemiology Studies","volume":"25","author":"Sinha","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Hua, H., Meydan, C., Afshin, E.E., Lili, L.N., D\u2019Adamo, C.R., Rickard, N., Dudley, J.T., Price, N.D., Zhang, B., and Mason, C.E. (2022). A Wipe-Based Stool Collection and Preservation Kit for Microbiome Community Profiling. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.889702"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/aje\/kww177","article-title":"Comparison of Collection Methods for Fecal Samples in Microbiome Studies","volume":"185","author":"Vogtmann","year":"2017","journal-title":"Am. J. Epidemiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7543\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:05:24Z","timestamp":1787652324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":110,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177543"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177543","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}